Tobacco Studies Program

Smoking Cessation Integrated Care Model and Mental Health Populations

June 3, 2009

Smoking Cessation Integrated Care Model and Mental Health Populations

Andrew Saxon, MD

Tobacco Related Health Disparities: The Case of Tobacco (HSERV 556)

Andrew Saxon pic Dr. Saxon is a Professor of Psychiatry and Behavioral Sciences at the University of Washington, where he is Director of the Addiction Psychiatry Residency Program. His current research work involves pharmacotherapies and psychotherapies for alcohol, cocaine, methamphetamine, nicotine, and opioid dependence as well as work in co-occurence of substance dependence and posttraumatic stress disorder. Dr. Saxon is board certified with added qualifications in addiction psychiatry by the American Board of Psychiatry and Neurology. He serves as one of five National Clinical Experts on office-based treatment of opioid dependence with buprenorphine for the Physician Clinical Suppport System, a national mentoring network for physicians. Dr. Saxon is also the Medical Director of the SAMHSA funded Physician Clinical Support System for Methadone. He sits on the editorial boards of the journals, Drug and Alcohol Dependence and General Hospital Psychiatry.
Biosketch: here

This lecture is also part of our Tobacco-Related Health Disparities (HSERV 556) course, where it is paired with the following readings:
Saxon A.J. et al. (2003). Smoking Cessation Treatment Among Dually Diagnosed Individuals: Preliminary Evaluation of Different Pharmocotherapies. Nicotine and Tobacco Research, 5(4), 589-96.

Williams, J. M., & Ziedonis, D. (2004). Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors, 29(6), 1067-1083.